临床肝胆病杂志2023，Vol.39Issue(12)：2793-2797,5.DOI:10.3969/j.issn.1008-794X.2023.10.001
复合式冷热消融系统治疗原发性肝癌中国专家共识(2023)
Chinese expert consensus on Co-Ablation System for the treatment of primary liver cancer(2023 edition)
摘要
Abstract
Clinically,the recurrence and metastasis of liver cancer after local ablation therapy have been the main factors affecting the long-term survival of patients with liver cancer.As a new generation of composite cryoablation and thermal ablation system,Co-Ablation System creatively integrates the advantages of profound hypothermia cryoablation and thermal ablation,which can maximize the release of tumor antigen while completely destroying liver cancer in situ,thus,the purpose of controlling liver cancer recurrence and metastasis can be achieved.Co-Ablation System treatment is usually carried out through percutaneous puncture under ultrasound or CT guidance.The selection of local anesthesia or general anesthesia is based on the size and location of the liver cancer.Co-Ablation System treatment is mainly suitable for single tumor with diameter＜5 cm and multiple tumors(≤3 tumor lesions)with a maximum diameter＜3 cm.After ablation,protection of liver function and symptomatic treatment are employed according to patient's condition.About one month after ablation,MRI or contrast-enhanced CT examination is performed to evaluate the therapeutic efficacy,then,the patients are followed up regularly.In order to standardize the application of Co-Ablation System in treating liver cancer,the Committee of Minimally Invasive Therapy in Oncology and the Committee of Ablation Therapy in Oncology,Chinese Anti-Cancer Association,have organized domestic experts engaged in liver cancer ablation therapy to make a professional and in-depth discussion and to compose this expert consensus on Co-Ablation System for the treatment of primary liver cancer.关键词
原发性肝癌/复合式冷热消融系统/操作规范/专家共识Key words
Primary Liver Cancer/Co-Ablation System/Operation Specification/Expert Consensus引用本文复制引用
中国抗癌协会肿瘤微创治疗专业委员会,中国抗癌协会肿瘤消融治疗专业委员会,史瑶平,孟志强,翟博..复合式冷热消融系统治疗原发性肝癌中国专家共识(2023)[J].临床肝胆病杂志,2023,39(12):2793-2797,5.基金项目
国家重点研发计划资助(2020YFC0122305) National Key Research and Development Program(2020YFC0122305) （2020YFC0122305）
